-
Governance and Nominating Committee
Governance and Nominating Committee
Victor Micati (Chairman)
Robert LeBuhn
Robert Salisbury
Richard Mulligan
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) |  | +0.04 | |
| Volume | 652143 | ||
| 9:02 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
12-01-2008
Enzon Discontinues its Plan to...
Enzon Discontinues its Plan to Spin-off its Biotechnology Business
-
03-19-2009
Enzon Treats Patients with Sur...
Enzon Treats Patients with Survivin Antagonist
-- Enzon's compound advances into the clinic for patients with solid tumors and lymphomas-- -
05-06-2009
Enzon Reaches Phase II Dose fo...
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027-- -
11-29-2007
Enzon to Present at BMO Capita...
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
-
05-06-2009
Enzon Reaches Phase II Dose fo...
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027-- -
10-20-2008
Enzon Presents New Data on its...
Enzon Presents New Data on its LNA Programs
--Platform shows promise-- -
12-08-2008
Enzon Pharmaceuticals Commence...
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
-
02-14-2008
Enzon Reports Significant Prog...
Enzon Reports Significant Progress on the Reduction of Its Debt